Aclarion (NASDAQ:ACONW) Shares Up 40.7% – Still a Buy?

Aclarion, Inc. (NASDAQ:ACONWGet Free Report) shares were up 40.7% during trading on Monday . The stock traded as high as $0.20 and last traded at $0.10. Approximately 375,211 shares changed hands during mid-day trading, an increase of 299% from the average daily volume of 93,972 shares. The stock had previously closed at $0.07.

Aclarion Stock Up 40.7 %

The firm has a fifty day simple moving average of $0.05 and a 200 day simple moving average of $0.04.

About Aclarion

(Get Free Report)

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.

Featured Articles

Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.